Announcements Trials
Browse Landscape

Status

Completed 109Terminated 24Withdrawn 10Unknown 10Recruiting 5Not yet recruiting 3Active not recruiting 3Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Follicular 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma 7Lymphoma, Large B-Cell, Diffuse 6Leukemia, Lymphocytic, Chronic, B-Cell 6Neoplasms 5Lymphoma, Non-Hodgkin 5Leukemia, Myeloid, Acute 5Myelodysplastic Syndromes 4Multiple Myeloma 4Recurrence 3Pain 3Lymphoma, B-Cell 3Hematologic Neoplasms 3Anxiety Disorders 3Prostatic Neoplasms 2Lymphoproliferative Disorders 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell, Marginal Zone 2Lung Neoplasms 2Leukemia, B-Cell 2Leukemia 2Irritable Bowel Syndrome 2Hypertension 2Hodgkin Disease 2Depression 2Dementia 2Cognitive Dysfunction 2Atrial Fibrillation 2Asthma 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Intraocular Lymphoma × Lymphoid × Clear all
NCT06650358 2024-10-21

Clinical Outcomes of Patients with LAL+ in At Least One Eye

Bucci Laser Vision Institute

Enrolling by invitation
25 enrolled
Lymphoid

Cataract, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡